Researchers at Griffith University‘s Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs. The Parkinson’s response is just the start.
The corresponding author, Professor Ronald Quinn AM said testing the new process on a marine sponge had delivered not only confirmation that the system is effective, but also a potential lead in the fight against Parkinson’s disease.
“We have found a new screening method which allows us to identify novel molecules drawn from nature to test for biological activity,” Professor Quinn said.
“As it happens, the first new compound we discovered through this process has demonstrated a response in Parkinson’s disease cells.”
Prestigious chemistry journal Angewandte Chemie has published the results in “NMR Fingerprints of the Drug-like Natural Product Space: Iotrochotazine A, a Chemical Probe to Study Parkinson’s Disease”.
The first author Dr Tanja Grkovic said the screening process involves nuclear magnetic resonance (NMR) spectroscopy; a highly sensitive instrument through which it is possible to see natural products weighing as little as 20 micrograms, which is less than a grain of salt.
“When you are searching for nature-derived molecules, the jackpot is finding something that nobody has ever seen before and rather than just a variation on a known theme,” Dr Grkovic said.
“We began the project by selecting 20 marine sponge samples randomly from Griffith’s Nature Bank facility and using the NMR technique trying to visualise all the small molecules which could meet the requirements for a potential new drug.
“The idea was to look at patterns of data and identify unusual or unique sets. We followed one such pattern and isolated a natural product with a novel skeleton which has turned out to be a molecule which was completely unknown previously.”
Griffith’s Nature Bank is a unique drug discovery resource based on natural products found in Australia, China and Papua New Guinea. It comprises more than 45,000 samples of plants and marine invertebrates, 200,000 semi-purified fractions, 3,250 pure compounds and over 600 naturally-occurring fragments.
This NMR screening process provides a new way of searching all those natural samples stored in Nature Bank and uncovering the potential biological activity of the compounds within them.
Deputy Director of the Eskitis Institute and co-author of the paper, Associate Professor George Mellick, is a specialist researcher in neurodegenerative diseases such as Parkinson’s disease. He is delighted by the research prospects this new molecule may provide.
“What is very intriguing about this novel natural product is that, while we have found it has an effect on cells sourced from a Parkinson’s patient, it showed a different biological activity on cells from healthy individuals,” Associate Professor Mellick said.
“This provides us with a new tool to study the fundamental biology of Parkinson’s and to get a better understanding of the cellular processes involved in the development of this disease.
But the Parkinson’s response is just the start.
“This new research technique opens the door to unlimited opportunities, both in terms of chemistry and biology research at Eskitis, as we continue the search for new therapies against disease,” Professor Quinn said.
The Latest on: New drugs from nature
via Google News
The Latest on: New drugs from nature
- Homeless, mentally ill — and facing prison time for taking four pairs of socks from NYC department store that cracks down on shoplifterson September 8, 2019 at 8:00 am
The practice, which New York County Defender Services says was employed last ... He was off his medications, living on the street and using street drugs when the guard caught him with the socks.
- New AI Model Shortens Drug Discovery to Days, Not Yearson September 6, 2019 at 4:18 pm
In an AI milestone in life sciences, Insilico Medicine announced a new machine learning tool for drug discovery that can generate a novel molecule in days instead of years and published their findings ...
- New structure for human flu virus proteinon September 6, 2019 at 4:56 am
Recently published in Nature, they used several different techniques ... inhibiting the flu virus which means we could develop new drugs and flu treatments in the future. A structure and function ...
- Fluorinated compounds present opportunities for drug discoveryon September 4, 2019 at 10:13 am
In these respects, the use of amides in drugs follows nature’s example — amide groups provide the ... drug-discovery programmes — some of these compounds might well display new biological activities.
- AI-powered drug discovery in days, not yearson September 4, 2019 at 12:08 am
According to BenchSci, artificial intelligence can aid pharmaceutical drug development by ... accessible for the first time to the public." The new research has been published in the journal Nature ...
- New study suggests breast cancer 'hibernates' to stop drugs from workingon September 3, 2019 at 1:22 am
Dr Luca Magnani, who led the study published in the journal Nature Communications, said the findings could lead to new drugs which could keep dormant cells permanently asleep or kill them. Almost ...
- PastCast: Monoclonal antibodies, from basic science to blockbuster drugson August 30, 2019 at 6:42 am
In the Nature PastCast series ... Between 1997 and 2011, the Food and Drugs Administration approved between one and four new monoclonal antibodies per year. Amongst those antibodies were Rituxan or ...
- High-Tech Imagery May Lead to New Drugs to Treat Therapy-Induced Nausea in Cancer Patientson July 23, 2019 at 11:12 am
Published in Nature Communications ... Without a precise model, drug developers have been unable to understand exactly which elements of setron-receptor interactions are most important, and how to ...
- Learning from nature's bounty: New libraries for drug discoveryon June 11, 2019 at 7:11 am
Natural products, or their close derivatives, make some of our most potent medicines, among which macrocycles with their large carbon-rich ring systems are one class. The size and complexity of ...
- Learning from nature's bounty: New libraries for drug discoveryon June 10, 2019 at 5:00 pm
Natural products make some of our most potent medicines, among which macrocycles with their large carbon-rich ring systems are one class. Their size and complexity has made it difficult to emulate on ...
via Bing News